Cargando…
肺癌PD1/PD-L1免疫检查点治疗疗效预测标志物第18届世界肺癌大会相关研究综述
Programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) checkpoint blockades have dramatically changed the treatment of non-small cell lung cancer (NSCLC). But we still have no definite biomarkers that may predict the efficacy of treatment by PD-1/PD-L1 inhibitors. In the 18(th) World...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137004/ https://www.ncbi.nlm.nih.gov/pubmed/30201070 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.09.09 |